MAPT and Alzheimer disease: These authors also described an intracellular form of clusterin in AD model mice and humans, showed its association with the AD risk Clu SNP and that intracellular clusterin interacted with another GWAS hit, BIN1, to drive Tau pathology in AD, thereby identifying a pathway that linked two genetic associations.